GlassScriptPhysician profile
Satish C Singla
NPI 1730186396
$6,735.72
in general payments reported to CMS, 2019-2025
50 companies · $1,659 in 2025
The $1,659 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $425 · 2021: $1,145 · 2022: $921 · 2023: $1,188 · 2024: $616 · 2025: $1,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Education: $289 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,006.94 |
| Education | $289.07 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,795.83 | 2019-2025 | |
| Eisai INC. | $431.66 | 2019-2025 | |
| Genentech USA, INC. | $359.91 | 2019-2025 | Polivy, Venclexta, Gazyva |
| Bayer Healthcare Pharmaceuticals INC. | $333.81 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $320.60 | 2019-2025 | Keytruda |
| Pfizer INC. | $312.46 | 2023-2025 | |
| Janssen Biotech, INC. | $218.29 | 2019-2025 | Talvey, Darzalex, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $208.70 | 2019-2025 | Opdivo |
| Gilead Sciences, INC. | $170.78 | 2021-2025 | Trodelvy |
| Lilly USA, LLC | $161.36 | 2022-2023 | Verzenio, Jaypirca |
| Daiichi Sankyo INC. | $155.25 | 2024-2025 | Enhertu, Datroway |
| Biogen, INC. | $150.00 | 2021 | |
| Emd Serono, INC. | $139.16 | 2023-2025 | |
| Astellas Pharma US INC | $134.74 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.80 | 2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.